InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,183.93
(
0.06%
)
US TECH 100
17,588.40
(
-0.12%
)
Dow Jones
38,867.74
(
0.04%
)
Brent Oil
83.13
(
-0.42%
)
Bitcoin
63,036.56
(
-0.21%
)
Post# of 458486
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jimmy667

Send PM Follow Ignore
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

jimmy667

Re: XenaLives post# 187664

Saturday, 03/30/2019 3:12:51 PM

Saturday, March 30, 2019 3:12:51 PM

Post# of 458486
Based on my non-professional and cursory knowledge and understanding of the claimed MOA of A2-73 addressing misfolded proteins which as I understand it are expressions of genes not based on DNA (epigenetic) and if the true experts are right that RETT is epigenetic, misfolded proteins during gene expression then it would seem that Anavex is at least targeting the right pathway for treating RETT as well as other epigenetic disorders like Epilepsy.
No wonder Dr Kaufmann is now Anavex CMO and no wonder the preeminent Epilepsy researcher Dr Andrew Cole is on Anavex Board of Scientific Advisors. (He is on the SAB of only one other Company- Sage, also of the ERP Consortium)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!